Assignee
DELTA 4 GMBH
AT·0 granted patents·4 pending applications·0 citations·filing 2021–2021
Top patents by PatentIndex Score
4 records- 0139US2024041825A1Saroglitazar and myristic acid for use in the treatment of focal segmental glomerulosclerosis (fsgs)DELTA 4 GMBH·Filed 2021·Application pending·0 cites
- 0239US2024016785A1Clopidogrel for use in the treatment of focal segmental glomerulosclerosis (fsgs)DELTA 4 GMBH·Filed 2021·Application pending·0 cites
- 0339US2024058298A1Genistein for use in the treatment of focal segmental glomerulosclerosis (fsgs)DELTA 4 GMBH·Filed 2021·Application pending·0 cites
- 0437US2023270826A1Antiviral use of liraglutide and gefitinibDELTA 4 GMBH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DELTA 4 GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →